PAI
Palo Alto Investors Portfolio holdings
AUM
$470M
This Quarter Return
+5.13%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$1.75B
AUM Growth
+$1.75B
(+1.8%)
Cap. Flow
+$62.9M
Cap. Flow
% of AUM
3.59%
Top 10 Holdings %
Top 10 Hldgs %
73.68%
Holding
42
New
–
Increased
21
Reduced
7
Closed
4
Top Buys
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$18.6M |
| 2 |
United Therapeutics
UTHR
|
$15.1M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$14M |
| 4 |
ZLTQ
ZELTIQ Aesthetics, Inc.
ZLTQ
|
$13.3M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
$5.51M |
Top Sells
| 1 |
ENDP
Endo International plc
ENDP
|
$19M |
| 2 |
CEMP
Cempra, Inc.
CEMP
|
$7.01M |
| 3 |
Rigel Pharmaceuticals
RIGL
|
$2.4M |
| 4 |
Talphera
TLPH
|
$1.56M |
| 5 |
ACGN
Aceragen, Inc. Common Stock
ACGN
|
$963K |
Sector Composition
| 1 | Healthcare | 92.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
United Therapeutics
UTHR
$13.8B
| $268M | 15.29% | 1,868,815 +105,357 | +6% | +$15.1M |
|
|
ABMD
2
DELISTED
Abiomed Inc
ABMD
| $214M | 12.24% | 1,903,584 +19,200 | +1% | +$2.16M |
|
|
CLVS
3
DELISTED
Clovis Oncology, Inc.
CLVS
| $169M | 9.64% | 3,804,088 | – | – |
|
|
4
BioMarin Pharmaceuticals
BMRN
$11.2B
| $162M | 9.26% | 1,960,219 +169,320 | +9% | +$14M |
|
|
AMAG
5
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $116M | 6.64% | 3,344,620 +17,900 | +0.5% | +$623K |
|
|
ALXN
6
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $87.3M | 4.98% | 713,742 +152,042 | +27% | +$18.6M |
|
|
ZLTQ
7
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $74.9M | 4.27% | 1,720,763 +306,200 | +22% | +$13.3M |
|
8
Insmed
INSM
$28.8B
| $72.1M | 4.11% | 5,446,516 +355,218 | +7% | +$4.7M |
|
9
Vanda Pharmaceuticals
VNDA
$279M
| $67M | 3.82% | 4,203,270 +92,562 | +2% | +$1.48M |
|
|
WMGI
10
DELISTED
Wright Medical Group Inc
WMGI
| $59.9M | 3.41% | 2,604,593 +164,100 | +7% | +$3.77M |
|
|
SAGE
11
DELISTED
Sage Therapeutics
SAGE
| $51.6M | 2.94% | 1,009,930 +107,879 | +12% | +$5.51M |
|
12
Prothena Corp
PRTA
$441M
| $48.9M | 2.79% | 993,855 +59,400 | +6% | +$2.92M |
|
13
Acadia Pharmaceuticals
ACAD
$4.38B
| $44.2M | 2.52% | 1,532,030 +50,100 | +3% | +$1.44M |
|
14
STAAR Surgical
STAA
$1.36B
| $36.7M | 2.1% | 3,386,245 +141,635 | +4% | +$1.54M |
|
|
EPZM
15
DELISTED
Epizyme, Inc
EPZM
| $36.7M | 2.1% | 3,035,796 +221,256 | +8% | +$2.68M |
|
|
CELG
16
DELISTED
Celgene Corp
CELG
| $34.2M | 1.95% | 295,240 +2,540 | +0.9% | +$294K |
|
|
ARIA
17
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $33.4M | 1.9% | 2,682,017 +94,400 | +4% | +$1.17M |
|
18
Amicus Therapeutics
FOLD
$2.34B
| $31.9M | 1.82% | 6,410,030 +724,642 | +13% | +$3.6M |
|
19
Karyopharm Therapeutics
KPTI
$61.7M
| $30.1M | 1.72% | 3,200,396 +114,547 | +4% | +$1.08M |
|
|
MNTA
20
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $26M | 1.48% | 1,727,380 +76,504 | +5% | +$1.15M |
|
21
Gilead Sciences
GILD
$140B
| $22.8M | 1.3% | 318,400 | – | – |
|
|
SHPG
22
DELISTED
Shire pic
SHPG
| $21.1M | 1.21% | 124,100 +900 | +0.7% | +$153K |
|
|
23
Rigel Pharmaceuticals
RIGL
$697M
| $9.94M | 0.57% | 4,176,623 -1,009,465 | -19% | -$2.4M |
|
|
AIMT
24
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $7.77M | 0.44% | 379,727 | – | – |
|
25
Exact Sciences
EXAS
$8.98B
| $5.3M | 0.3% | 396,976 | – | – |
|